Liang G, Kan S, Zhu Y, et al. Int J Nanomedicine. 2018;13:585–599.
On page 586, the 1st heading, right hand column should read “Materials and methods” instead of “Patients and methods”.
. 2018 Aug 7;13:4507. doi: 10.2147/IJN.S178282
Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]
Collection date 2018.
© 2018 Liang et al. This work is published and licensed by Dove Medical Press Limited
Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
PMCID: PMC6086565 PMID: 30122923
This corrects the article "Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells" on page 585.